AP Pharma Inc /DE/

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
AP Pharma Inc /DE/
TickerHRTX
CIK #0000818033
CUSIP427746102
SectorLife Sciences - Pharmaceutical Preparations
Address123 Saginaw Drive, Redwood City, CA 94063
Source [EDGAR]
CIK Filing 2011 - 2024
[0000818033] 10-K
[0000818033] 10-Q
[0000818033] 3
[0000818033] 4
[0000818033] 5
[0000818033] 8-K
[0000818033] D
[0000818033] SC 13D
[0000818033] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Great Point Partners LLC Heron Therapeutics Inc /DE/ [2023-04-13] 5.35
Rubric Capital Management LP Heron Therapeutics Inc /DE/ [2023-02-06] 0.9
Deep Track Capital LP Heron Therapeutics Inc /DE/ [2022-08-19] 0.99
UBS OConnor LLC Heron Therapeutics Inc /DE/ [2022-02-14] 8.12
State Street Corp Heron Therapeutics Inc /DE/ [2022-02-11] 7.55
JPMorgan Chase & Co Heron Therapeutics Inc /DE/ [2022-01-24] 6.1
ArrowMark Colorado Holdings LLC Heron Therapeutics Inc /DE/ [2021-02-16] 5.9
Tang Capital Partners LP Heron Therapeutics Inc /DE/ [2020-11-19] 9.86
Wellington Management Group LLP Heron Therapeutics Inc /DE/ [2019-02-12] 5.87
Vanguard Group Inc Heron Therapeutics Inc /DE/ [2019-02-11] 8.09
BlackRock Inc Heron Therapeutics Inc /DE/ [2019-02-08] 6.3
Janus Henderson Group PLC Heron Therapeutics Inc /DE/ [2017-06-12] 10.5
Kingdon Capital Management LLC Heron Therapeutics Inc /DE/ [2017-02-14] 0.82
BlackRock Inc Heron Therapeutics Inc /DE/ [2017-01-30] 5.5
Janus Capital Management LLC Heron Therapeutics Inc /DE/ [2016-02-16] 8.7
Invesco Ltd Heron Therapeutics Inc /DE/ [2016-02-10] 0.2
FMR LLC Heron Therapeutics Inc /DE/ [2015-10-09] 0.0
Cormorant Global Healthcare Master Fund LP Heron Therapeutics Inc /DE/ [2015-08-28] 5.6
Partner Fund Management LP Heron Therapeutics Inc /DE/ [2015-07-09] 5.6
Kingdon Capital Management LLC Heron Therapeutics Inc /DE/ [2015-06-08] 0.56
SPCH LLLP AP Pharma Inc /DE/ [2013-04-09] 0.0
Savitr Capital LLC AP Pharma Inc /DE/ [2013-02-15] 11.8
FMR LLC AP Pharma Inc /DE/ [2013-02-14] 0.0
Baker Bros Advisors LLC AP Pharma Inc /DE/ [2013-02-01] 9.9
Broadfin Capital LLC AP Pharma Inc /DE/ [2012-12-31] 5.14
SPCH LLLP AP Pharma Inc /DE/ [2012-09-27] 11.8
Hambrecht & Quist Capital Management LLC AP Pharma Inc /DE/ [2012-02-14] 0.7
Form 3/4/5 Filer 2011 - 2024
Forbes William P
Heron Therapeutics Inc /DE/
Collard Craig A
Szekeres David Leslie
Manhard Kimberly
Poyhonen John
Peraza Lisa
Kotler Kevin
Morgan Adam
Rosen David Efraim
Rubric Capital Management LP
Venkataraman Balaji
Velan Capital Management LLC
Velan Capital Master Fund LP
Velan Capital Investment Management LP
Velan Capital Holdings LLC
Quart Barry D
Dissanaike Sharmila
Christian Waage
Rodriguez Susan
Johnson Craig A
Davis Stephen
Tang Kevin C
Hoffman Robert E.
Rosen Robert
Tang Capital Management LLC
Tang Capital Partners LP
Drazba Brian G.
Marshall Paul
Clendeninn Neil James
Midler Andrew R
SPCH LLC
Savitr Capital, LLC
Gelder Mark S. MD
Whelan John
Adam Michael A
Goddard Paul
Turnbull Greg
Form 13F Holdings
Firm Period DFND Voting Shares
Franklin Resources Inc [2023-03-31] DFND 11,868,996.0 11,870,096.0
Rubric Capital Management LP [2023-03-31] SOLE 11,750,000.0 11,750,000.0
BlackRock Inc. [2023-03-31] SOLE 9,049,626.0 9,401,084.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 8,174,976.0
Baker Bros Advisors LP [2023-03-31] SOLE 8,131,678.0 8,131,678.0
JPMorgan Chase & Co [2023-03-31] DFND 6,068,959.0 7,086,791.0
Great Point Partners LLC [2023-03-31] DFND 0.0 5,817,368.0
Velan Capital Investment Management LP [2023-03-31] SOLE 4,500,000.0 4,500,000.0
Palisade Capital Management LP [2023-03-31] SOLE 2,776,735.0 3,970,286.0
ArrowMark Colorado Holdings LLC [2023-03-31] SOLE 3,337,314.0 3,337,314.0
Deep Track Capital LP [2023-03-31] SOLE 3,234,722.0 3,234,722.0
State Street Corp [2023-03-31] DFND 2,343,576.0 2,555,993.0
Clearline Capital LP [2023-03-31] SOLE 2,089,292.0 2,089,292.0
Geode Capital Management LLC [2023-03-31] DFND 1,974,954.0 1,974,954.0
Tejara Capital Ltd [2023-03-31] SOLE 1,667,519.0 1,667,519.0
Orchard Capital Management LLC [2023-03-31] SOLE 1,391,080.0 1,391,080.0
Renaissance Technologies LLC [2023-03-31] SOLE 1,140,836.0 1,140,836.0
New York State Common Retirement Fund [2023-03-31] SOLE 1,071,124.0 1,071,124.0
Citadel Advisors LLC [2023-03-31] DFND 1,065,199.0 1,065,199.0
Northern Trust Corp [2023-03-31] DFND 52,602.0 983,299.0
OrbiMed Advisors LLC [2023-03-31] SOLE 0.0 802,700.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 731,126.0 731,126.0
D. E. Shaw & Co., Inc. [2023-03-31] DFND 719,827.0 721,082.0
Nuveen Asset Management LLC [2023-03-31] DFND 721,031.0 721,031.0
Los Angeles Capital Management LLC [2023-03-31] SOLE 32,219.0 705,677.0
Pekin Hardy Strauss Inc [2023-03-31] SOLE 350,000.0 571,705.0
Woodline Partners LP [2023-03-31] SOLE 569,212.0 569,212.0
Millennium Management LLC [2023-03-31] SOLE 565,788.0 565,788.0
Tang Capital Management LLC [2023-03-31] OTR 0.0 550,000.0
HRT Financial LP [2023-03-31] DFND 547,365.0 547,365.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com